Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases

The problem of coronavirus disease 2019 (COVID-19) still remains relevant even now, after two years. As one of the methods of combating the current COVID-19 pandemic, most experts suggest the widespread use of vaccination. The use of anticovid vaccines in patients with rheumatic diseases raises a nu...

Full description

Saved in:
Bibliographic Details
Main Authors: B. B. BELOV, N. V. MURAVYEVA, A. N. KULIKOV
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2022-09-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/930
Tags: Add Tag
No Tags, Be the first to tag this record!